These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33446415)

  • 1. Insomnia matters in myasthenia gravis.
    Kalita J; Dongre N; Misra UK
    Sleep Med; 2021 Mar; 79():221-222. PubMed ID: 33446415
    [No Abstract]   [Full Text] [Related]  

  • 2. Myasthenic crisis due to anxiety and insomnia during COVID -19 pandemic.
    Kalita J; Dongre N; Misra UK
    Sleep Med; 2020 Nov; 75():532-533. PubMed ID: 32839085
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?
    Rzepiński Ł; Wawrzyniak S; Maciejek Z
    Neurol Neurochir Pol; 2020; 54(5):481-482. PubMed ID: 33006133
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of Insomnia and Anxiety in Myasthenia Gravis.
    Jordan H; Ortiz N
    J Neuropsychiatry Clin Neurosci; 2019; 31(4):386-391. PubMed ID: 31177904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on COVID-19 in patients with myasthenia gravis.
    Galassi G; Marchioni A
    Muscle Nerve; 2020 Dec; 62(6):E85-E86. PubMed ID: 32929765
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of Acute Insomnia and Anxiety in a Patient With Myasthenia Gravis and Respiratory Failure.
    Benjelloun R; Aasfara J; Otheman Y
    Prim Care Companion CNS Disord; 2022 Jan; 24(1):. PubMed ID: 35086182
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
    Ramaswamy SB; Govindarajan R
    J Neuromuscul Dis; 2020; 7(3):361-364. PubMed ID: 32508329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Before classifying exacerbation in myasthenia as crisis, comprehensive work-up is warranted.
    Finsterer J; Ghosh R
    Sleep Med; 2021 Mar; 79():220. PubMed ID: 33461847
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infections, pandemics and sleep disorders].
    Kolokolov OV; Salina EA; Yudina VV; Shuldyakov AA; Runnova AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(4. Vyp. 2):68-74. PubMed ID: 34078863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on COVID-19 in patients with myasthenia gravis: Author response.
    Anand P; Slama MCC; Kaku M; Ong C; Cervantes-Arslanian AM; Zhou L; David WS; Guidon AC
    Muscle Nerve; 2020 Dec; 62(6):E87-E88. PubMed ID: 32954519
    [No Abstract]   [Full Text] [Related]  

  • 11. The acute effects of the COVID-19 pandemic on insomnia and psychological symptoms.
    Morin CM; Carrier J
    Sleep Med; 2021 Jan; 77():346-347. PubMed ID: 32595107
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia Gravis Associated With SARS-CoV-2 Infection.
    Restivo DA; Centonze D; Alesina A; Marchese-Ragona R
    Ann Intern Med; 2020 Dec; 173(12):1027-1028. PubMed ID: 32776781
    [No Abstract]   [Full Text] [Related]  

  • 13. Speculative clues on Myasthenia gravis and COVID-19.
    Scoppetta C; Casciato S; Di Gennaro G
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7925-7926. PubMed ID: 32767317
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of patients with generalised myasthenia gravis and COVID-19: four case reports.
    Hübers A; Lascano AM; Lalive PH
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1124-1125. PubMed ID: 32651248
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.
    Hoang P; Hurtubise B; Muppidi S
    Neurology; 2020 Nov; 95(18):840-843. PubMed ID: 32817186
    [No Abstract]   [Full Text] [Related]  

  • 16. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
    Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
    Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 and generalized Myasthenia Gravis exacerbation: A case report.
    Singh S; Govindarajan R
    Clin Neurol Neurosurg; 2020 Sep; 196():106045. PubMed ID: 32634699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic health record derived-impact of COVID-19 on myasthenia gravis.
    Roy B; Kovvuru S; Nalleballe K; Onteddu SR; Nowak RJ
    J Neurol Sci; 2021 Apr; 423():117362. PubMed ID: 33639420
    [No Abstract]   [Full Text] [Related]  

  • 19. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19.
    Abu-Rumeileh S; Garibashvili T; Ruf W; Fangerau T; Kassubek J; Althaus K; Otto M; Senel M
    J Neurol Sci; 2020 Nov; 418():117106. PubMed ID: 32911389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubíková et al.
    Galassi G; Marchioni A
    Eur J Neurol; 2022 Jan; 29(1):e5-e6. PubMed ID: 34586695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.